Angiogenesis therapy against cerebral ischemic disease
血管生成治疗脑缺血性疾病
基本信息
- 批准号:17591521
- 负责人:
- 金额:$ 2.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hyoxia-inducible factor 1(HIF-1) is a transcription factor that regulates the adaptive response to hypoxia in mammalian cells. It consists of a regulatory subunit HIF-1α, which accumulates under hypmic conditions, and constitutively expressed subunit, HIF-1β. We investigated HIF-1α naked DNA-induced angiogenesis in a cerebral ischemic model in vivo. We utilized a rat encephalo-myo-synangiosis model and inoculated HIF-1α naked DNA on the brain surface or temporal muscle. We analyzed HIF-1α induced angiogenic factors and collateral circulation. A histological section treated with HIF-1α DNA showed an increased expression of HIF-1α and VEGF with collateral circulation, in comparison with control DNA HIF-1α transcription factor is able to promote significant angiogenesis development.Geranylgeranylacetone (GGA) is known as an antinuclear agent and more recently as a heat shock protein (HSP) inducer. This study evaluated the neuroprotective effect of GGA against cerebral infarction induced by permanent left middle cerebral artery (MCA) occlusion in rats. GGA was given orally in various regimens prior to MCA ocdusion Pretreatment with a single oral GGAdose (800 mg/kg) 48 hours before ischemia significantly attenuated cerebral infarction volume. A significant increase in HSP70 immunoreactivity was found in the neocortex in GGA-treated animals with or without ischemia. Pretreatment with a single oral dose of GGA provides an important tool for exploring the mechanisms of neuroprotection against cerebral ischemic neuronal damage.
低氧诱导因子1(HIF-1)是一种调节哺乳动物细胞低氧适应性反应的转录因子。它由调节亚基HIF-1α和组成型表达亚基HIF-1β组成。我们研究了HIF-1α裸DNA在体内脑缺血模型中诱导的血管生成。我们利用大鼠脑-肌-血管结合模型,将HIF-1α裸DNA接种于脑表面或颞肌。分析HIF-1α诱导的血管生成因子和侧支循环。与对照组相比,HIF-1α DNA处理的组织切片显示HIF-1α和VEGF的表达增加。HIF-1α转录因子能够促进显著的血管生成。本研究旨在探讨银杏叶提取物对大鼠大脑中动脉(MCA)永久性闭塞所致脑梗死的保护作用。缺血前48 h单次口服GGA(800 mg/kg)可明显缩小脑梗死体积。一个显着增加HSP 70的免疫反应性被发现在新皮质在GGA治疗的动物有或无缺血。单次口服GGA预处理为探索脑缺血性神经元损伤的神经保护机制提供了重要工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Geranylgeranylacetone,a noninvasive heat shock protein inducer,induces protein kinase C and leads to neuroprotection against cerebral infarction in rats
香叶基香叶基丙酮是一种非侵入性热休克蛋白诱导剂,可诱导蛋白激酶 C 并导致大鼠脑梗塞的神经保护作用
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Akagawa H;Kasuya H;et al.;Kasuya et al.;Fujiki M;Uchida S
- 通讯作者:Uchida S
Geranylberanylacetone, a noninvasive heat shock protein inducer induces protein kinase C and leads to neuroprotection against cerebral infarction in rats.
Geranylberanylacetone 是一种非侵入性热休克蛋白诱导剂,可诱导蛋白激酶 C,从而对大鼠脑梗塞产生神经保护作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Anan;M.;Abe;T.;Matsuda;T.;Ishii;K.;Kamida;T.;Fujiki;M.;Kobayashi;H.;阿部竜也;Fujiki M;Fujiki M;Hashimoto S;Fujiki M;Anan M;Uchida S
- 通讯作者:Uchida S
Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment
- DOI:10.1016/j.neulet.2006.07.005
- 发表时间:2006-09-25
- 期刊:
- 影响因子:2.5
- 作者:Fujiki, Minoru;Hikawa, Takarnitsu;Kobayashi, Hidenori
- 通讯作者:Kobayashi, Hidenori
血管新生研究と脳神経外科治療への展開
血管生成研究和神经外科治疗的进展
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Akagawa H;Tajima A;Sakamoto Y;Krischek B;Yoneyama T;Kasuya H 他;Morishige M;阿部 竜也
- 通讯作者:阿部 竜也
Induced angiogenesis under cerebral ischemia by cyclo-oxygenase 2 and hypoxia-inducible factor naked DNA in a To indirect-bypass model
To 间接旁路模型中环加氧酶 2 和缺氧诱导因子裸 DNA 诱导脑缺血下血管生成
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Anan;M.;Abe;T.;Matsuda;T.;Ishii;K.;Kamida;T.;Fujiki;M.;Kobayashi;H.
- 通讯作者:H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOBAYASHI Hidenori其他文献
KOBAYASHI Hidenori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOBAYASHI Hidenori', 18)}}的其他基金
Molecular biological study on ischemic cerebral injury.
缺血性脑损伤的分子生物学研究。
- 批准号:
10470287 - 财政年份:1998
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Effects of hypoxia on ischemic delayd neuronal death
缺氧对缺血性迟发性神经元死亡的影响
- 批准号:
07457311 - 财政年份:1995
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Policy Studies for Accelerated Modernization in Shanghai
上海加快现代化建设的政策研究
- 批准号:
06041102 - 财政年份:1994
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
- 批准号:
23K06972 - 财政年份:2023
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Type I Interferon Mediated Restoration of Brain Endothelial Cell Function after Cerebral Infarction
I型干扰素介导脑梗塞后脑内皮细胞功能的恢复
- 批准号:
10606276 - 财政年份:2023
- 资助金额:
$ 2.28万 - 项目类别:
Cell therapy research using human umbilical cord blood-derived hemangioblast-like cells for the treatment of cerebral infarction
人脐带血成血管样细胞治疗脑梗塞的细胞治疗研究
- 批准号:
22K09221 - 财政年份:2022
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vitro cerebral infarction model using assembloid culture system
使用Assembloid培养系统建立体外脑梗死模型
- 批准号:
22K16685 - 财政年份:2022
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Prospective study for cerebral infarction after transcatheter aortic valve replacement in low risk patients
低危患者经导管主动脉瓣置换术后脑梗死的前瞻性研究
- 批准号:
22K16563 - 财政年份:2022
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of innovative treatments using next-generation exosomes for cerebral infarction
使用下一代外泌体开发脑梗塞创新疗法
- 批准号:
22K09239 - 财政年份:2022
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical study to prevent the pulmonary vein stump thrombus and cerebral infarction after left side pulmonary resection
预防左侧肺切除术后肺静脉残端血栓及脑梗死的临床研究
- 批准号:
21K16522 - 财政年份:2021
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of new function of Noggin, a BMP inhibitor, in cerebral infarction and spinal cord injury
阐明BMP抑制剂Noggin在脑梗塞和脊髓损伤中的新功能
- 批准号:
21H02655 - 财政年份:2021
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Recovery of paralysis after cerebral infarction and analysis of molecular mechanisms based on O-GlcNAc modification in the brain
脑梗塞后瘫痪的恢复及基于O-GlcNAc脑内修饰的分子机制分析
- 批准号:
20K11197 - 财政年份:2020
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimal rehabilitation conditions for cerebral infarction following intravenous infusion of mesenchymal stem cells
间充质干细胞静脉输注脑梗死最佳康复条件
- 批准号:
20K11212 - 财政年份:2020
- 资助金额:
$ 2.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




